CLOSE ×
×

    Use our advanced search tool to find the exact model you need.

    Model Search  
    B0071 landing page image

    FENS Forum 2022

    Meet our team in Paris, France in booth #72 from July 10-13 to explore how our expanded portfolio of research models and services can support your neuroscience research.

    Learn more  
    Group of business people

    Career opportunities at Envigo

    If you would like to become part of the team that shapes our future, then visit our careers portal for our current vacancies.

    Careers Portal  
    product-guide-homepage-sub-web-feature

    Envigo’s 2022 product guide

    Let us help you achieve your unique research goals. Access our latest product guide to explore our expanded research models and services.

    Download today  

    Latest events

    Latest news

    Scientific insights

    European Association for Cancer Research 2022
    June 20-23, 2022 Envigo to exhibit at the 28th Congress of the European Association for Cancer Research EACR 2022 is a four day congress dedicated to basic, preclinical...
    FENS 2022
    July 9-13, 2022 Founded in 1998 at the first Forum of European Neuroscience, the Federation of European Neuroscience Societies (FENS) is the main organization...
    ICT (IUTOX/EUROTOX) 2022
    September 18-21, 2022 The Dutch Society of Toxicology (NVT) will host the XVI International Congress of Toxicology in Maastricht, the Netherlands, in Se...
    All latest events  
    Inotiv, Inc. completes purchase of Envigo
    Creates a full-spectrum discovery-to-approval solution for drug developers WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Ino...
    Envigo announces collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
    Indianapolis, Indiana, USA, September 28th, 2021 — Envigo RMS Holding Corp. (or Envigo) announces a collaboration with
    Inotiv, Inc. and Envigo propose to join forces to enhance research and drug discovery solutions
    WEST LAFAYETTE, Ind. and INDIANAPOLIS, Ind.; Sept. 21, 2021 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contrac...
    All latest news  
    White paper

    The Negative Impacts of Pinworms in Laboratory Animal Research

    Pinworms are an insidious and common threat to research utilizing laboratory mice and rats. This pest can adversely affect the reproducibility and reliability of research findings. Moreover, the parasitic load and adverse effects caused by pinworms can be even more pronounced in immunodeficient animals.

    Case study

    Cannulock™ Buttons Extend Catheter Patency in Rodents

    Looking to enhance the 3Rs and increase catheter patency at the same time? Cannulock™ Buttons can help. This innovative closed system improves animal and technician welfare while increasing catheter patency.

    White paper

    PDX, CDX and Allograft Growth in the R2G2® Mouse

    Three recent studies made it clear: the R2G2® mouse is well suited for preclinical cancer studies that generate PDX, CDX and allograft models. The R2G2® mouse exhibited reduced radiosensitivity compared to NSGTM mice and tolerated estrogen supplementation and three standard-of-care chemotherapy drugs reasonably well. Moreover, as compared to other traditionally used immunodeficient strains, the R2G2® mouse had higher take rates and more favorable tumor growth.

    All Scientific Insights  

    No video selected

    Select a video type in the sidebar.